Starving cancer cells: could cholesterol drugs slow pancreatic tumors?
NCT ID NCT04862260
First seen Mar 29, 2026 · Last updated May 28, 2026 · Updated 8 times
Summary
This early study tests whether adding three cholesterol-lowering drugs (atorvastatin, ezetimibe, and evolocumab) to standard chemotherapy can slow or stop pancreatic cancer growth. Cancer cells need lots of cholesterol to grow, and this approach aims to starve them. The trial includes 3 adults with advanced or metastatic pancreatic cancer who have not yet had treatment. The main goal is to check if the drug combination is safe and feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Québec-Université Laval
Québec, Quebec, G1R 2J6, Canada
-
CHUM
Montreal, Quebec, H2X 0A9, Canada
Conditions
Explore the condition pages connected to this study.